UK Drug Company GlaxoSmithKline (GSK) With a Stock Market Cap of US$86 Bil Had 37% of Its 2016 Total Revenues Made To US Customers and 22% of Its 2016 Total Non-Current Assets Including Property, Plant and Equipment Located in the US
From GSK's US SEC Filings
